USAID · CENTRE FOR INFECTIOUS DISEASE RESEARCH IN ZAMBIA — $37.6M (ZMB)
Key claim: USAID obligated $37.6 million to the Centre for Infectious Disease Research in Zambia for Service Delivery for HIV Prevention (SDHP) among at-risk populations in Zambia.
Abstract
Agency for International Development obligated $37.6M to CENTRE FOR INFECTIOUS DISEASE RESEARCH IN ZAMBIA, for work in ZMB. SERVICE DELIVERY FOR HIV PREVENTION (SDHP): THE ACTIVITY SEEKS TO IMPROVE THE HEALTH OUTCOMES OF ZAMBIANS BY PREVENTING NEW HIV INFECTIONS AMONG POPULATIONS MOST AT RISK OF ACQUIRING HIV.
Why this matters
This obligation places a mid-sized ($25M–$100M) USAID bilateral HIV prevention award with a Zambian domestic research institution, adding Zambia to the area’s map of country-level PEPFAR service delivery channels. Alongside Partners in Hope (Malawi), Baylor Malawi, Moi/AMPATH (Kenya), and ICAP (DRC), it fills in the Southern African HIV service-delivery footprint funded through in-country recipients rather than US-based primes.